· My cancer treatment is over for now, so where is my sense of relief? →
I still have follow-up appointments next week and a PET scan in August that will show if the tumor is completely gone and whether or not the cancer spread.
· David van Dijk: The Role of Machine Learning in Biomedical Discovery →
Scientists use RNA sequencing to measure cell activity in a tumor and understand the complexity of the tumor.
· Week In Review: CanSino Publishes Positive Data From Trial Of COVID-19 Vaccine →
Apollomics, a US-China biopharma, will start a global Phase II trial of its c-MET inhibitor in two indications: non-small cell lung cancer (NSCLC) patients with a mutation that leads to MET exon 14 skipping, and patients who have any tumor type with MET amplification or fusions.
· Transgene and NEC Demonstrate High Accuracy of AI-based Neoantigen Prediction for the Design of Individualized Cancer Vaccine TG4050 →
Healthy and tumor tissue were sequenced, and mutations were identified and ranked using the algorithm.
· Cel-Sci: A Zombie Biotech Company →
The therapy being they are focused on now is called Multikine and is a cocktail of cytokines intended to be injected into the tumor site of Head and Neck cancer patients.
The New York Times
· Virus Lockdown Forces Iran Into Its First Virtual Quds Day →
Mr. Khamenei, reading from a prepared script, compared Israel to a “cancerous tumor in the region” that must be removed and to the coronavirus as “a reality that all wise people consider it mandatory to fight.”